ALSTON & BIRD LLP

Lobbying for KERECIS · Biotechnology Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $60,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Medicare/Medicaid

General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.

Health Issues

General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.